UCB launches successful bond issue on NYSE Euronext


Brussels, 27 March 2013– NYSE Euronext (NYX) today announced a successful €250 million bond issue on its Brussels-market by UCB, the Belgium-based global biopharmaceutical group.

UCB focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With around 9.000 people in about 40 countries, the company generated revenue of €3.4 billion in 2012.

The bonds, issued by UCB on 7 years with a maturity date in 2020, have been entirely subscribed for the maximum amount of €250 million. Consequently, the subscription period was closed early. The UCB bonds, priced at a nominal of €1000, offer a coupon of 3.75% per year.

“We are delighted with the success of UCB’s  bond offering on NYSE Euronext”, said Vincent Van Dessel, Chairman and CEO of NYSE Euronext Brussels.“Bonds offer businesses an attractive source of additional funding that is both flexible and efficient, and we are convinced that the bond offering encourages individual investors to return to the market.” Alain Baetens, Head of Listings Belgium at NYSE Euronext, adds:“Our goal at NYSE Euronext is to channel domestic savings back into productive investment and allow the stock exchange to steadily increase its contribution to financing the real economy.”

BNP Paribas Fortis, ING Belgium and KBC Bank acted as joint lead managers for the issue of this bond.

To celebrate the new listing, Roch Doliveux, CEO of UCB, rang the bell to open trading on NYSE Euronext’s European market. He was accompanied by members of UCB’s management team as well as Vincent Van Dessel, Chairman and CEO of NYSE Euronext Brussels and the listing team.

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With more than 1,900 listed issuers and around €6.5 trillion in market capitalisation as of end June 2023, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2023, Euronext N.V. - All rights reserved.